Cite
HARVARD Citation
Tanaka, A. et al. (2016). Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome. International journal of cardiology. pp. 1-3. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tanaka, A. et al. (2016). Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome. International journal of cardiology. pp. 1-3. [Online].